REVIEWS / SMARTWATCHES / OWNER INSIGHTS
🦉 WE READ 120 OWNER COMMENTS
Apple Watch Series 9: what owners actually say
Most discussion around the Series 9 centers on the Masimo patent dispute and blood oxygen sensor ban, not the watch itself; actual owner feedback is sparse in this sample.
What owners complain about
- Blood oxygen sensor patent ban COMMON
The Series 9 was subject to a US import ban due to infringing Masimo's blood oxygen (SpO2) patent. Apple halted sales at its own stores, though third-party retailers like Best Buy and Target continued selling existing inventory. The blood oxygen feature was the specific casualty.
- Algorithm opacity hurts research credibility SOME
Commenters note Apple does not publish what changes in their health/heart-rate algorithms between generations, making it harder for researchers to validate or use Apple Watch data in studies compared to competitors.
- Pricing volatility on Amazon FEW
A commenter observed the Series 9 jumping from $429 to $449 on Amazon within a day, suspecting algorithmic price manipulation ahead of Black Friday.
- Availability uncertainty by region FEW
Depending on country, the Series 9 may no longer be sold by the time buyers look for it, with Apple already on Series 11/Ultra 3 in some markets.
What owners love
- S9 chip performance
One commenter found the S9 chip impressive, though this was more anticipation than deep ownership experience.
- Best 'true smartwatch' option
Commenters consistently position the Apple Watch as the go-to if you want a full-featured smartwatch, explicitly contrasted with Garmin which is recommended primarily for sport tracking rather than smart features.
- Competitive health data accuracy
A commenter referencing multiple studies (including an Antwerp 2025 study) noted the Apple Watch Series 8 was tested alongside current-gen WHOOP 4.0, Oura, and Fitbit devices, suggesting it holds up in accuracy comparisons — though concerns about mid-study algorithm updates were raised.
Surprising patterns
- The import ban only applied to Apple's own direct sales channels; third-party retailers could legally sell remaining inventory, meaning the ban's practical effect on availability was described as 'a bit lax' by commenters.
- Commenters speculated Apple may have welcomed the ban as cover for lower-than-expected sales figures, or as a board-level excuse — suggesting the commercial impact may have been less dire than headlines implied.
- Multiple commenters framed the patent dispute as ironic: Apple, which has aggressively used patents and import bans against competitors, was 'struck by the very thing they love to do.'
WHO SHOULD SKIP IT
Buyers who need a validated, research-grade health tracking device should hesitate, since commenters highlight Apple's lack of algorithm transparency and the blood oxygen sensor's disputed legal status.
Synthesised from 120 real owner comments across 4 platforms. Every point is grounded in the comments — no marketing, no AI guessing. How we do it →